Skin wound caused by external injury is usually difficult to be cured by conventional topical administration because of its poor drug diffusion across the stratum corneum. It has been recognized that stratum corneum is the major obstacle for transdermal drug delivery. To address this issue, microneedles (MNs) have been developed to penetrate the stratum corneum of the skin and then form micron-sized pores between the epidermis and the dermis layers. As such, biomacromolecule drugs and/or insoluble drug molecules can be allowed for effective transdermal penetration. A multifunctional microneedle array patch that can avoid wound infection and promote tissue remolding has important value for wound healing. Among others, marine polysaccharides have attracted much attention in multifarious biomedical applications due to their excellent (bio)physical and chemical properties. Herein, we developed a microneedle array patch using a blend of kangfuxin (KFX), chitosan (CS), and fucoidan (FD), named KCFMN, for accelerating full-thickness wound healing. The traditional Chinese medicine KFX extracted from Periplaneta americana (PA) has effective bio-functions in promoting wound healing. The macro-/micro-morphology and (bio)physicochemical properties of such composite microneedles were also studied. We showed that the KCFMN patch displayed noticeable antibacterial properties and good cytocompatibility. In particular, the KCFMN patch significantly accelerated the wound healing development in a full-thickness wound in rats by improving the epithelial thickness and collagen deposition. Thus, this versatile KCFMN patch has great prospects as a dressing for full-thickness wound healing.
1 December 2015 in Drug Design, Development and Therapy
This study aimed to evaluate the efficacy and safety of topical treatment with natural herbal medicines on recurrent aphthous stomatitis (RAS). Nine electronic databases were searched to identify the randomized controlled trials and clinical controlled trials that reported the potential effect of natural herbal medicines on RAS published in Chinese or English. Ulcer size and duration, and remission of pain were assessed as main outcome measures. The methodological quality of the studies was evaluated using the Cochrane Handbook for Systemic Review of Interventions and Rev Man software. Thirteen trials with a total of 1,515 patients were included in the present analysis, which showed that topical treatment with natural herbal medicines seemed to benefit RAS patients by reducing ulcer size, shortening ulcer duration, and relieving pain without severe side effects. In conclusion, there is some evidence of the efficacy of topically applied natural herbal medicines with regards to improved RAS outcome measures and fewer side effects. However, given the limitations of this study, the evidence remains insufficient. Well-designed and high-quality randomized controlled trials are required for further exploration.
Oral squamous cell carcinoma represents 90% of all oral cancers. Recurrence prevention remains an important prognostic factor in patients with oral squamous cell carcinoma, and the recovery of the oral epithelium post-surgery is still a challenge. Thus, there is an urgent need to develop a smart carrier material to realize the spatiotemporally controlled release of anticancer drugs, instead of multiple oral administrations, for recurrence prevention and promoting the reconstruction of injured epithelial tissues. Here, we developed a multi-layered nanofiber patch capable of the photothermal-triggered release of low-molecular-weight fucoidan (LMWF) from the sandwiched layer, together with electrospun fibers as the backing and top layers. The sandwiched layer was made of phase-change materials loaded with indocyanine green, a photosensitive dye, for the localized release of LMWF in response to near-infrared irradiation. We showed that the on-demand release of LMWF was able to kill oral cancer cells effectively. Furthermore, adding acellular dermal matrix to the top nanofiber layer improved the proliferation of human oral keratinocytes, while the hydrophobic back layer served as a barrier to prevent loss of the drug. Taken together, this study provides a feasible and smart material system for killing oral squamous cancer cells together with the recovery of oral epithelium.
3 December 2025 in Frontiers in Molecular Biosciences
Objective: To investigate the molecular interaction patterns between CD46/TREM1 and LC3B/ATG5 in the development of oral squamous cell carcinoma (OSCC), providing novel targets for elucidating the mechanism of inflammatory-to-cancer progression and for the early diagnosis and treatment of OSCC. Methods: An oral inflammation-to-cancer progression animal model was established using 4-Nitroquinoline-N-oxide (4-NQO) drinking water and/or lipopolysaccharide (LPS). Clinical oral leukoplakia (OLK), OSCC, and adjacent non-cancerous tissues were collected. Immunohistochemistry assessed CD46, TREM1, LC3B, ATG5 protein expression and PI3K-AKT/TNF pathway alterations in animal and clinical tissues. Enzyme-Linked Immunosorbent Assay (ELISA) measured inflammatory cytokine levels in serum and saliva. High-throughput sequencing analyzed key pathways. Results: Immunohistochemistry revealed elevated CD46/TREM1 expression and reduced LC3B/ATG5 expression in OSCC tissues ( P < 0.05). Serum levels of IL-6, IL-8, and GROα/CXCL1 progressively increased with advancing inflammation-to-cancer progression in rats, whereas salivary expression peaks occurred during the inflammatory phase. In human saliva and serum, TNF-α, IL-8, and IL-6 exhibited an increasing trend among healthy individuals, oral leukoplakia patients, and OSCC patients ( P < 0.05). Transcriptome analysis revealed a significant increase in differentially expressed genes during the transformation from OLK to OSCC, predominantly downregulated genes. Among these, Col4a6 and Csf2 genes participated in inflammation-to-cancer progression by regulating the PI3K-Akt and TNF pathways. Conclusion: CD46 and TREM1 are highly expressed in OSCC and serve as key initiating factors in the progression from OLK to OSCC. Bioinformatics analysis identified critical candidate genes ( Col4a6 , Csf2 ) and pathways (PI3K-Akt, TNF) in inflammation-to-cancer conversion. Activation of the PI3K-AKT-mTOR pathway is associated with inhibited autophagy and malignant progression of OSCC. Additionally, inflammation-to-cancer transition is a core mechanism in the development of OSCC, with the tumor inflammatory microenvironment acting as a “promoter” in the progression from OLK to OSCC. This study provides novel insights into the molecular mechanisms and targeted therapies for OSCC, holding significant theoretical and clinical application value.
Objective: This study aims to explore the regulatory effect of abnormal expression of CD46 and TREM1 on LC3B and ATG5 and to provide new targets for the molecular mechanism and treatment of OSCC. Methods: Human oral squamous cell carcinoma cells CAL-27 were selected for in vitro culture. For related research, the CD46 shRNA interference test, immunohistochemistry (IHC), flow cytometry, qRT-PCR detection, Western blot, and tumor-bearing animal models were used. Results: In vitro cell experiments showed that CD46 and TREM1 were highly expressed on the surface of OSCC cells, while the expression of LC3B and ATG5 was significantly decreased. Compared with the control group (SC-shRNA), the CD46 shRNA group could effectively reduce the expression of CD46 in OSCC cells and increase the expression of autophagy and apoptosis protein (P<0.01). In vivo experiments showed that the tumor volume of the shRNA group was significantly smaller than that of the SC-shRNA group (P<0.01), the expression of CD46 and TREM1 was decreased considerably, and the expression of LC3B and ATG5 was higher (P<0.01). Conclusion: OSCC cells have high expression of CD46 and TREM1, while low expression of LC3B and ATG5, and the autophagy apoptosis signal is weakened. Interfering with CD46 can up-regulate the expression of autophagy apoptosis genes, reduce the tumor inflammatory microenvironment, induce the apoptosis of OSCC cells, and inhibit the proliferation and metastasis of OSCC. This study provides a new idea for the mechanism and targeted therapy of OSCC and has important theoretical significance and clinical application value.